Skip to main content
Erschienen in: Die Gynäkologie 10/2021

03.09.2021 | Ultraschall | CME

Diagnostik und Therapie von benignen ovariellen Raumforderungen

verfasst von: Dr. med. Davut Dayan, Prof. Dr. Wolfgang Janni, Kerstin Pfister, Dr. med. Elena Leinert

Erschienen in: Die Gynäkologie | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Ovarialtumoren werden in die folgenden 3 Hauptkategorien eingeteilt: epitheliale, Keimzell- und Keimstrang-Stromatumoren. Im Hinblick auf die Dignität unterscheidet man zwischen benignen, malignen und Borderline-Befunden. Die häufigsten Ovarialtumoren sind gutartige epitheliale seröse Zystadenome. Ovarialtumoren sind in der Regel asymptomatisch und werden meistens als Zufallsbefund entdeckt. Um die adäquate Therapie planen zu können, ist die Abklärung des Befunds von großer Bedeutung, die mit Anamnese, körperlicher Untersuchung, laborchemischen Untersuchungen und der Sonographie als bildgebendem Goldstandard beginnt. Der therapeutische Ansatz muss die Differenzialdiagnose der Malignität sowie die hormonellen und reproduktiven Aspekte der Patientin umfassen. Die Standardtherapie ist bei fehlenden Malignitätskriterien in der Prämenopause die laparoskopische Zystenausschälung, in der Postmenopause die Adnexektomie. Bei vorliegenden Malignitätskriterien sollte unabhängig vom Menopausenstatus eine Adnexektomie zur Vermeidung eine Zellverschleppung durchgeführt werden.
Literatur
1.
Zurück zum Zitat Timmerman D, Valentin L, Bourne TH et al (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505 PubMedCrossRef Timmerman D, Valentin L, Bourne TH et al (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505 PubMedCrossRef
2.
Zurück zum Zitat Foti PV, Attina G, Spadola S et al (2016) MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging 7:21–41 PubMedCrossRef Foti PV, Attina G, Spadola S et al (2016) MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging 7:21–41 PubMedCrossRef
3.
Zurück zum Zitat WHO Classification of Tumours Editorial Board (2020) Female genital tumours, 5. Aufl. WHO classification of tumours, Bd. 4. IARC, Lyon WHO Classification of Tumours Editorial Board (2020) Female genital tumours, 5. Aufl. WHO classification of tumours, Bd. 4. IARC, Lyon
5.
Zurück zum Zitat Delaloye JF, Dreher E, Eberhard M, Fehr M, Haller U, Köchli O, Torhorst J (2004) Guideline: Der Adnexbefund. Schweiz Arzteztg 85:458–468 CrossRef Delaloye JF, Dreher E, Eberhard M, Fehr M, Haller U, Köchli O, Torhorst J (2004) Guideline: Der Adnexbefund. Schweiz Arzteztg 85:458–468 CrossRef
6.
Zurück zum Zitat American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology (2016) Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol 128:e210–e226 CrossRef American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology (2016) Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol 128:e210–e226 CrossRef
7.
Zurück zum Zitat Biggs WS, Marks ST (2016) Diagnosis and management of adnexal masses. Am Fam Physician 93:676–681 PubMed Biggs WS, Marks ST (2016) Diagnosis and management of adnexal masses. Am Fam Physician 93:676–681 PubMed
8.
Zurück zum Zitat Dodge JE, Covens AL, Lacchetti C et al (2012) Management of a suspicious adnexal mass: a clinical practice guideline. Curr Oncol 19:e244–e257 PubMedPubMedCentralCrossRef Dodge JE, Covens AL, Lacchetti C et al (2012) Management of a suspicious adnexal mass: a clinical practice guideline. Curr Oncol 19:e244–e257 PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Sehouli J, Akdogan Z, Heinze T et al (2003) Preoperative determination of CASA (cancer associated serum antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study. Anticancer Res 23:1115–1118 PubMed Sehouli J, Akdogan Z, Heinze T et al (2003) Preoperative determination of CASA (cancer associated serum antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study. Anticancer Res 23:1115–1118 PubMed
10.
Zurück zum Zitat Anastasi E, Granato T, Falzarano R et al (2013) The use of HE4, CA125 and CA72‑4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res 6:44 PubMedPubMedCentralCrossRef Anastasi E, Granato T, Falzarano R et al (2013) The use of HE4, CA125 and CA72‑4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res 6:44 PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Carvalho JP, Moretti-Marques R, Filho A (2020) Adnexal mass: diagnosis and management. Rev Bras Ginecol Obstet 42:438–443 PubMedCrossRef Carvalho JP, Moretti-Marques R, Filho A (2020) Adnexal mass: diagnosis and management. Rev Bras Ginecol Obstet 42:438–443 PubMedCrossRef
12.
Zurück zum Zitat Holcomb K, Vucetic Z, Miller MC et al (2011) Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Am J Obstet Gynecol 205:358.e1–358.e6 CrossRef Holcomb K, Vucetic Z, Miller MC et al (2011) Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Am J Obstet Gynecol 205:358.e1–358.e6 CrossRef
13.
Zurück zum Zitat Huhtinen K, Suvitie P, Hiissa J et al (2009) Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 100:1315–1319 PubMedPubMedCentralCrossRef Huhtinen K, Suvitie P, Hiissa J et al (2009) Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 100:1315–1319 PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Prakash A, Li T‑C, Ledger WL (2004) The management of ovarian cysts in premenopausal women. Obstet Gynaecol 6:12–15 Prakash A, Li T‑C, Ledger WL (2004) The management of ovarian cysts in premenopausal women. Obstet Gynaecol 6:12–15
15.
Zurück zum Zitat Chudecka-Glaz AM (2015) ROMA, an algorithm for ovarian cancer. Clin Chim Acta 440:143–151 PubMedCrossRef Chudecka-Glaz AM (2015) ROMA, an algorithm for ovarian cancer. Clin Chim Acta 440:143–151 PubMedCrossRef
16.
Zurück zum Zitat Romagnolo C, Leon AE, Fabricio ASC et al (2016) HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study. Gynecol Oncol 141:303–311 PubMedCrossRef Romagnolo C, Leon AE, Fabricio ASC et al (2016) HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study. Gynecol Oncol 141:303–311 PubMedCrossRef
17.
Zurück zum Zitat Jeong YY, Outwater EK, Kang HK (2000) Imaging evaluation of ovarian masses. Radiographics 20:1445–1470 PubMedCrossRef Jeong YY, Outwater EK, Kang HK (2000) Imaging evaluation of ovarian masses. Radiographics 20:1445–1470 PubMedCrossRef
18.
Zurück zum Zitat Sassone AM, Timor-Tritsch IE, Artner A et al (1991) Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 78:70–76 PubMed Sassone AM, Timor-Tritsch IE, Artner A et al (1991) Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 78:70–76 PubMed
19.
Zurück zum Zitat Schwärzler P, Timmerman D (2018) IOTA-Modelle zur Beurteilung von Adnexbefunden. Gynäkologe 51:178–187 CrossRef Schwärzler P, Timmerman D (2018) IOTA-Modelle zur Beurteilung von Adnexbefunden. Gynäkologe 51:178–187 CrossRef
20.
Zurück zum Zitat Timmerman D, Ameye L, Fischerova D et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839 PubMedPubMedCentralCrossRef Timmerman D, Ameye L, Fischerova D et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839 PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Givens V, Mitchell GE, Harraway-Smith C et al (2009) Diagnosis and management of adnexal masses. Am Fam Physician 80:815–820 PubMed Givens V, Mitchell GE, Harraway-Smith C et al (2009) Diagnosis and management of adnexal masses. Am Fam Physician 80:815–820 PubMed
22.
Zurück zum Zitat Guerriero S, Saba L, Alcazar JL et al (2015) Past, present and future ultrasonographic techniques for analyzing ovarian masses. Womens Health 11:369–383 Guerriero S, Saba L, Alcazar JL et al (2015) Past, present and future ultrasonographic techniques for analyzing ovarian masses. Womens Health 11:369–383
23.
Zurück zum Zitat Asuncion M, Calvo RM, San Millan JL et al (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434–2438 PubMed Asuncion M, Calvo RM, San Millan JL et al (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434–2438 PubMed
24.
Zurück zum Zitat Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006–4011 PubMedCrossRef Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006–4011 PubMedCrossRef
25.
Zurück zum Zitat Farah L, Lazenby AJ, Boots LR et al (1999) Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 44:870–874 PubMed Farah L, Lazenby AJ, Boots LR et al (1999) Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 44:870–874 PubMed
26.
Zurück zum Zitat Knochenhauer ES, Key TJ, Kahsar-Miller M et al (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078–3082 PubMed Knochenhauer ES, Key TJ, Kahsar-Miller M et al (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078–3082 PubMed
27.
Zurück zum Zitat Lie Fong S, Laven JSE, Duhamel A et al (2017) Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Mullerian hormone using cluster analysis. Hum Reprod 32:1723–1731 PubMedCrossRef Lie Fong S, Laven JSE, Duhamel A et al (2017) Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Mullerian hormone using cluster analysis. Hum Reprod 32:1723–1731 PubMedCrossRef
28.
Zurück zum Zitat Balen AH, Laven JS, Tan SL et al (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505–514 PubMedCrossRef Balen AH, Laven JS, Tan SL et al (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505–514 PubMedCrossRef
29.
Zurück zum Zitat Rosenfield RL (2020) Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol 33:445–447 PubMedCrossRef Rosenfield RL (2020) Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol 33:445–447 PubMedCrossRef
30.
Zurück zum Zitat Timmons D, Montrief T, Koyfman A et al (2019) Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med 37:1577–1584 PubMedCrossRef Timmons D, Montrief T, Koyfman A et al (2019) Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med 37:1577–1584 PubMedCrossRef
31.
Zurück zum Zitat Navot D, Bergh PA, Laufer N (2019) Reprint of: Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 112:e209–e221 PubMedCrossRef Navot D, Bergh PA, Laufer N (2019) Reprint of: Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 112:e209–e221 PubMedCrossRef
32.
Zurück zum Zitat Bohiltea RE, Cirstoiu MM, Turcan N et al (2016) Ultrasound diagnostic of mesonephric paraovarian cyst—case report. J Med Life 9:280–283 PubMedPubMedCentral Bohiltea RE, Cirstoiu MM, Turcan N et al (2016) Ultrasound diagnostic of mesonephric paraovarian cyst—case report. J Med Life 9:280–283 PubMedPubMedCentral
33.
Zurück zum Zitat Sapmaz T, Gundogdu LS, Cetin MT et al (2019) The ultrastructural effects of surgical treatment of hydrosalpinx on the human endometrium: a light and electron microscopic study. Ultrastruct Pathol 43:99–109 PubMedCrossRef Sapmaz T, Gundogdu LS, Cetin MT et al (2019) The ultrastructural effects of surgical treatment of hydrosalpinx on the human endometrium: a light and electron microscopic study. Ultrastruct Pathol 43:99–109 PubMedCrossRef
34.
Zurück zum Zitat Parihar M, Mirge A, Hasabe R (2009) Hydrosalpinx functional surgery or salpingectomy? The importance of hydrosalpinx fluid in assisted reproductive technologies. J Gynecol Endosc Surg 1:12–16 PubMedPubMedCentralCrossRef Parihar M, Mirge A, Hasabe R (2009) Hydrosalpinx functional surgery or salpingectomy? The importance of hydrosalpinx fluid in assisted reproductive technologies. J Gynecol Endosc Surg 1:12–16 PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Savelli L, De Iaco P, Ghi T et al (2004) Transvaginal sonographic appearance of peritoneal pseudocysts. Ultrasound Obstet Gynecol 23:284–288 PubMedCrossRef Savelli L, De Iaco P, Ghi T et al (2004) Transvaginal sonographic appearance of peritoneal pseudocysts. Ultrasound Obstet Gynecol 23:284–288 PubMedCrossRef
36.
Zurück zum Zitat Seidman JD, Mehrotra A (2005) Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous „cystadenomas“ and „cystadenofibromas“. Gynecol Oncol 96:395–401 PubMedCrossRef Seidman JD, Mehrotra A (2005) Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous „cystadenomas“ and „cystadenofibromas“. Gynecol Oncol 96:395–401 PubMedCrossRef
37.
Zurück zum Zitat Limaiem F, Lekkala MR, Mlika M (2020) Ovarian cystadenoma. StatPearls, Treasure Island Limaiem F, Lekkala MR, Mlika M (2020) Ovarian cystadenoma. StatPearls, Treasure Island
38.
Zurück zum Zitat Burney RO, Giudice LC (2019) Reprint of: Pathogenesis and pathophysiology of endometriosis. Fertil Steril 112:e153–e161 PubMedCrossRef Burney RO, Giudice LC (2019) Reprint of: Pathogenesis and pathophysiology of endometriosis. Fertil Steril 112:e153–e161 PubMedCrossRef
39.
Zurück zum Zitat Buzinskiene D, Mongirdas M, Mikenas S et al (2019) Chemical peritonitis resulting from spontaneous rupture of a mature ovarian cystic teratoma: a case report. Acta Med Litu 26:217–226 PubMedPubMedCentral Buzinskiene D, Mongirdas M, Mikenas S et al (2019) Chemical peritonitis resulting from spontaneous rupture of a mature ovarian cystic teratoma: a case report. Acta Med Litu 26:217–226 PubMedPubMedCentral
40.
Zurück zum Zitat Rha SE, Byun JY, Jung SE et al (2004) Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR Am J Roentgenol 183:743–750 PubMedCrossRef Rha SE, Byun JY, Jung SE et al (2004) Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR Am J Roentgenol 183:743–750 PubMedCrossRef
41.
Zurück zum Zitat Rouanet JP, Maubon A, Juhan V et al (2000) Imaging of benign ovarian tumors. J Radiol 81:1823–1830 PubMed Rouanet JP, Maubon A, Juhan V et al (2000) Imaging of benign ovarian tumors. J Radiol 81:1823–1830 PubMed
42.
Zurück zum Zitat Outwater EK, Siegelman ES, Hunt JL (2001) Ovarian teratomas: tumor types and imaging characteristics. Radiographics 21:475–490 PubMedCrossRef Outwater EK, Siegelman ES, Hunt JL (2001) Ovarian teratomas: tumor types and imaging characteristics. Radiographics 21:475–490 PubMedCrossRef
43.
Zurück zum Zitat Sahin H, Abdullazade S, Sanci M (2017) Mature cystic teratoma of the ovary: a cutting edge overview on imaging features. Insights Imaging 8:227–241 PubMedPubMedCentralCrossRef Sahin H, Abdullazade S, Sanci M (2017) Mature cystic teratoma of the ovary: a cutting edge overview on imaging features. Insights Imaging 8:227–241 PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Weiss JR, Burgess JR, Kaplan KJ (2006) Fetiform teratoma (homunculus). Arch Pathol Lab Med 130:1552–1556 PubMedCrossRef Weiss JR, Burgess JR, Kaplan KJ (2006) Fetiform teratoma (homunculus). Arch Pathol Lab Med 130:1552–1556 PubMedCrossRef
46.
Zurück zum Zitat Caspi B, Appelman Z, Rabinerson D et al (1997) The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women. Fertil Steril 68:501–505 PubMedCrossRef Caspi B, Appelman Z, Rabinerson D et al (1997) The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women. Fertil Steril 68:501–505 PubMedCrossRef
47.
Zurück zum Zitat Chen VW, Ruiz B, Killeen JL et al (2003) Pathology and classification of ovarian tumors. Cancer 97:2631–2642 PubMedCrossRef Chen VW, Ruiz B, Killeen JL et al (2003) Pathology and classification of ovarian tumors. Cancer 97:2631–2642 PubMedCrossRef
48.
Zurück zum Zitat Comerci JT Jr, Licciardi F, Bergh PA et al (1994) Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol 84:22–28 PubMed Comerci JT Jr, Licciardi F, Bergh PA et al (1994) Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol 84:22–28 PubMed
49.
50.
Zurück zum Zitat McCluggage WG, Chong AL, De Kock L et al (2020) Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms. Histopathology 77:223–230 PubMedCrossRef McCluggage WG, Chong AL, De Kock L et al (2020) Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms. Histopathology 77:223–230 PubMedCrossRef
51.
Zurück zum Zitat Mooney EE, Nogales FF, Bergeron C et al (2002) Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology 41:110–117 PubMedCrossRef Mooney EE, Nogales FF, Bergeron C et al (2002) Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology 41:110–117 PubMedCrossRef
52.
Zurück zum Zitat Oliva E, Alvarez T, Young RH (2005) Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 29:143–156 PubMedCrossRef Oliva E, Alvarez T, Young RH (2005) Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 29:143–156 PubMedCrossRef
53.
Zurück zum Zitat Stacher E, Pristauz G, Scholz HS et al (2010) Bilateral ovarian well-differentiated Sertoli-Leydig cell tumors with heterologous elements associated with unilateral serous cystadenoma—a case report. Int J Gynecol Pathol 29:419–422 PubMedCrossRef Stacher E, Pristauz G, Scholz HS et al (2010) Bilateral ovarian well-differentiated Sertoli-Leydig cell tumors with heterologous elements associated with unilateral serous cystadenoma—a case report. Int J Gynecol Pathol 29:419–422 PubMedCrossRef
54.
Zurück zum Zitat Makhija A, Patel BM, Kenkre MA et al (2020) Retrospective analysis of 32 cases of ovarian granulosa cell tumours. J Obstet Gynaecol India 70:50–56 PubMedCrossRef Makhija A, Patel BM, Kenkre MA et al (2020) Retrospective analysis of 32 cases of ovarian granulosa cell tumours. J Obstet Gynaecol India 70:50–56 PubMedCrossRef
Metadaten
Titel
Diagnostik und Therapie von benignen ovariellen Raumforderungen
verfasst von
Dr. med. Davut Dayan
Prof. Dr. Wolfgang Janni
Kerstin Pfister
Dr. med. Elena Leinert
Publikationsdatum
03.09.2021
Verlag
Springer Medizin
Erschienen in
Die Gynäkologie / Ausgabe 10/2021
Print ISSN: 2731-7102
Elektronische ISSN: 2731-7110
DOI
https://doi.org/10.1007/s00129-021-04854-w

Weitere Artikel der Ausgabe 10/2021

Die Gynäkologie 10/2021 Zur Ausgabe

Einführung zum Thema

Metabolismus und Hormone

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.